Detalhe da pesquisa
1.
Clinical Investigation of Metabolic and Renal Clearance Pathways Contributing to the Elimination of Fevipiprant Using Probenecid as Perpetrator.
Drug Metab Dispos
; 49(5): 389-394, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33632715
2.
A Study of the Effect of Cyclosporine on Fevipiprant Pharmacokinetics and its Absolute Bioavailability Using an Intravenous Microdose Approach.
Drug Metab Dispos
; 48(10): 917-924, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32739890
3.
Fevipiprant has a low risk of influencing co-medication pharmacokinetics: Impact on simvastatin and rosuvastatin in different SLCO1B1 genotypes.
Pulm Pharmacol Ther
; 57: 101809, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31195091
4.
A First-in-Human Study To Assess the Safety and Pharmacokinetics of Monoclonal Antibodies against Human Cytomegalovirus in Healthy Volunteers.
Antimicrob Agents Chemother
; 60(5): 2881-7, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26926639
5.
Bioequivalence of Canakinumab Injected Subcutaneously via an Autoinjector Device or a Prefilled Safety Syringe Device in Healthy Subjects.
Clin Pharmacol Drug Dev
; 7(8): 829-836, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29676864